EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Post-Pandemic Burden of Illness Among Patients in Germany Aged ≥60 Years with Acute or Persistent COVID-19

Mousumi Biswas, James Lucas, Tendai Mugwagwa, Eveline Otte im Kampe, Mohammad Ashraf Chaudhary, Abid Kabir, Emily Quinones, James Piercy, Ruth Mokgokong

COVID · 11.11.2026 · 6 (11) · 202

DOI: 10.3390/covid6110202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift COVID, online erschienen am 11.11.2026. Verfasst von Mousumi Biswas und 8 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Adelphi Real World, Pfizer Inc..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Post-pandemic, real-world evidence on COVID-19 in elderly patients in Germany is limited. This study describes the clinical characteristics, treatment patterns, quality of life, and healthcare resource use among elderly patients with COVID-19.

Methods

Data were derived from the Adelphi Real World COVID Disease-Specific Programme™, a cross-sectional survey of physicians and patients aged ≥60 years with acute (≤4 weeks post-diagnosis) or persistent (symptom duration ≥ 12 weeks) COVID-19 from January to July 2024. Analyses were descriptive; comparisons between groups were not performed.

Results

151 physicians provided data for 400 patients (acute COVID-19, n = 200; persistent COVID-19, n = 200). The mean patient age was 68.1 (acute) and 70.1 (persistent) years. Most patients were male (acute, 56.0%; persistent, 58.5%) and retired (acute, 68.0%; persistent, 78.5%). The most common concomitant condition was hypertension (acute, 37.5%; persistent, 35.5%). Tiredness/fatigue was the most common physician-reported symptom (57.5% acute; 67.5% persistent). For patients with acute COVID-19 that received prescribed treatment (n = 62/200, 31.0%), antivirals were most commonly used (n = 59/62, 95.2%). Mean number of consultations from the index COVID-19 diagnosis to survey date was 2.7 over a median of 17.0 days (Q1–Q3: 7.0–44.0) and 5.0 over a median of 164.0 days (Q1–Q3: 128.0–225.0) for patients with acute or persistent COVID-19, respectively. Self-reported data were provided by 98 (acute) and 107 (persistent) patients. The most common patient-reported worst symptoms were headaches (n = 15/98, 15.3%; acute) and tiredness (n = 14/107, 13.1%; persistent). Mean EQ-5D-5L index score (German weighting) was 0.79 for both groups. EQ-VAS scores were 66.1 (acute) and 66.0 (persistent).

Conclusions

Elderly patients with acute or persistent COVID-19 have a notable burden of illness. Prioritizing care and interventions in these populations in the post-pandemic era is warranted.

Förderung

  • Adelphi Real World
  • Pfizer Inc.

Zitieren

APA

Biswas, M., Lucas, J., Mugwagwa, T., Kampe, E. O. I., Chaudhary, M. A., Kabir, A., Quinones, E., Piercy, J., & Mokgokong, R. (2026). Post-Pandemic Burden of Illness Among Patients in Germany Aged ≥60 Years with Acute or Persistent COVID-19. COVID, 6(11), 202. https://doi.org/10.3390/covid6110202

Vancouver

Biswas M, Lucas J, Mugwagwa T, Kampe EOI, Chaudhary MA, Kabir A, et al. Post-Pandemic Burden of Illness Among Patients in Germany Aged ≥60 Years with Acute or Persistent COVID-19. COVID. 2026;6(11):202. doi:10.3390/covid6110202

BibTeX
@article{Biswas2026,
  author = {Biswas, Mousumi and Lucas, James and Mugwagwa, Tendai and Kampe, Eveline Otte im and Chaudhary, Mohammad Ashraf and Kabir, Abid and Quinones, Emily and Piercy, James and Mokgokong, Ruth},
  title = {Post-Pandemic Burden of Illness Among Patients in Germany Aged ≥60 Years with Acute or Persistent COVID-19},
  journal = {COVID},
  year = {2026},
  volume = {6},
  number = {11},
  pages = {202},
  doi = {10.3390/covid6110202}
}
Kostenlos starten →